Literature DB >> 1586045

Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients.

D W Pennington1, W M Gold, R L Gordon, D Steiger, E J Ring, J A Golden.   

Abstract

Pulmonary arteriovenous malformations (AVM) lead to chronic hypoxemia and systemic emboli. These lesions can now be treated by catheter embolization. In order to examine physiologic abnormalities during exercise in AVM patients, and to evaluate functional improvement after therapeutic embolization, eight patients underwent detailed physiologic studies at rest and during exercise before and after therapeutic embolization. Before treatment, six patients noted dyspnea on exertion and three had symptoms suggesting paradoxical embolism. Resting studies showed hypoxemia, abnormally increased shunt fractions, chronic alveolar hyperventilation, mild decreases in diffusing capacity, and abnormal wasted ventilation (VD). During exercise, oxygenation changed little from the resting values but VD increased markedly. Functional impairment was observed in most patients, and was correlated with shunt fraction. Obliteration of the AVM was accomplished by therapeutic embolization with placement of coils or balloons in the feeder vessels. This treatment resulted in immediate relief of dyspnea and improvement in resting PaO2 and shunt fraction. Exercise studies after embolization showed improvement in exercise capacity and gas exchange. However, chronic alveolar hyperventilation and reduced diffusing capacity remained unchanged. In summary, therapeutic embolization effectively reduces the degree of shunting, with improvement in respiratory symptoms, exercise capacity, and gas exchange at rest and during exercise. The abnormally decreased diffusing capacity and increased VD suggest the presence of a diffuse pulmonary vascular abnormality, of which further study is warranted.

Entities:  

Mesh:

Year:  1992        PMID: 1586045     DOI: 10.1164/ajrccm/145.5.1047

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  The pulmonary physician in critical care * Illustrative case 7: Assessment and management of massive haemoptysis.

Authors:  J L Lordan; A Gascoigne; P A Corris
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

3.  Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis.

Authors:  Yasunori Ichimura; Kenji Tsushima; Takuma Matsumura; Kazutaka Yamagishi; Mitsuhiro Abe; Jun Ikari; Jiro Terada; Koichiro Tastumi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

5.  Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations.

Authors:  Vatshalan Santhirapala; Louisa C Williams; Hannah C Tighe; James E Jackson; Claire L Shovlin
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  Effect of pulmonary arteriovenous malformations on the mechanical properties of the lungs.

Authors:  Cécile Rotenberg; Marcel Bonay; Mostafa El Hajjam; Sandra Blivet; Alain Beauchet; Pascal Lacombe; Thierry Chinet
Journal:  BMC Pulm Med       Date:  2017-04-19       Impact factor: 3.317

7.  Imitators of exercise-induced bronchoconstriction.

Authors:  Pnina Weiss; Kenneth W Rundell
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-17       Impact factor: 3.406

8.  Coil Embolotherapy of Unilateral Diffuse Pulmonary Arteriovenous Malformations in a Nineteen-Year-Old Woman.

Authors:  Hadi Rokni Yazdi; Hamidreza Abtahi; Hazhir Saberi; Mona Salahi
Journal:  Iran J Radiol       Date:  2015-07-22       Impact factor: 0.212

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.